14 results on '"Rodts, U."'
Search Results
2. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases
- Author
-
Bousquet, J., Nhan, P.T., Bedbrook, A., Agache, I., Annesi-Maesano, I., Ansotegui, I., Anto, J.M., Bachert, C., Benveniste, S., Bewick, M., Billo, N., Bosnic-Anticevich, S., Bosse, I., Brusselle, G., Calderon, M.A., Canonica, G.W., Caraballo, L., Cardona, V., Carriazo, A.M., Cash, E., Cecchi, L., Chu, D.K., Colgan, E., Costa, E., Cruz, A.A., Czarlewski, W., Durham, S., Ebisawa, M., Erhola, M., Fauquert, J.L., Fokkens, W.J., Fonseca, J.A., Guldemond, N., Iinuma, T., Illario, M., Klimek, L., Kuna, P., Kvedariene, V., Larenas-Linneman, D., Laune, D., L.T.T. le, Lourenco, O., Malva, J.O., Marien, G., Menditto, E., Mullol, J., Munter, L., Okamoto, Y., Onorato, G.L., Papadopoulos, N.G., Perala, M., Pfaar, O., Phillips, A., Phillips, J., Pinnock, H., Portejoie, F., Quinones-Delgado, P., Rolland, C., Rodts, U., Samolinski, B., Sanchez-Borges, M., Schunemann, H.J., Shamji, M., Somekh, D., Togias, A., Toppila-Salmi, S., Tsiligianni, I., Usmani, O., Walker, S., Wallace, D., Valiulis, A., Kleij, R. van der, Ventura, M.T., Williams, S., Yorgancioglu, A., and Zuberbier, T.
- Published
- 2019
3. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)
- Author
-
Bousquet, J. Pham-Thi, N. Bedbrook, A. Agache, I. Annesi-Maesano, I. Ansotegui, I. Anto, J.M. Bachert, C. Benveniste, S. Bewick, M. Billo, N. Bosnic-Anticevich, S. Bosse, I. Brusselle, G. Calderon, M.A. Canonica, G.W. Caraballo, L. Cardona, V. Carriazo, A.M. Cash, E. Cecchi, L. Chu, D.K. Colgan, E. Costa, E. Cruz, A.A. Czarlewski, W. Durham, S. Ebisawa, M. Erhola, M. Fauquert, J.-L. Fokkens, W.J. Fonseca, J.A. Guldemond, N. Iinuma, T. Illario, M. Klimek, L. Kuna, P. Kvedariene, V. Larenas-Linneman, D. Laune, D. Le, L.T.T. Lourenço, O. Malva, J.O. Marien, G. Menditto, E. Mullol, J. Münter, L. Okamoto, Y. Onorato, G.L. Papadopoulos, N.G. Perala, M. Pfaar, O. Phillips, A. Phillips, J. Pinnock, H. Portejoie, F. Quinones-Delgado, P. Rolland, C. Rodts, U. Samolinski, B. Sanchez-Borges, M. Schünemann, H.J. Shamji, M. Somekh, D. Togias, A. Toppila-Salmi, S. Tsiligianni, I. Usmani, O. Walker, S. Wallace, D. Valiulis, A. Van der Kleij, R. Ventura, M.T. Williams, S. Yorgancioglu, A. Zuberbier, T.
- Published
- 2019
4. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1)
- Author
-
Bousquet, J. Pham-Thi, N. Bedbrook, A. Agache, I. Annesi-Maesano, I. Ansotegui, I. Anto, J.M. Bachert, C. Benveniste, S. Bewick, M. Billo, N. Bosnic-Anticevich, S. Bosse, I. Brusselle, G. Calderon, M.A. Canonica, G.W. Caraballo, L. Cardona, V. Carriazo, A.M. Cash, E. Cecchi, L. Chu, D.K. Colgan, E. Costa, E. Cruz, A.A. Czarlewski, W. Durham, S. Ebisawa, M. Erhola, M. Fauquert, J.-L. Fokkens, W.J. Fonseca, J.A. Guldemond, N. Iinuma, T. Illario, M. Klimek, L. Kuna, P. Kvedariene, V. Larenas-Linneman, D. Laune, D. Le, L.T.T. Lourenço, O. Malva, J.O. Marien, G. Menditto, E. Mullol, J. Münter, L. Okamoto, Y. Onorato, G.L. Papadopoulos, N.G. Perala, M. Pfaar, O. Phillips, A. Phillips, J. Pinnock, H. Portejoie, F. Quinones-Delgado, P. Rolland, C. Rodts, U. Samolinski, B. Sanchez-Borges, M. Schünemann, H.J. Shamji, M. Somekh, D. Togias, A. Toppila-Salmi, S. Tsiligianni, I. Usmani, O. Walker, S. Wallace, D. Valiulis, A. Van Der Kleij, R. Ventura, M.T. Williams, S. Yorgancioglu, A. Zuberbier, T.
- Published
- 2019
5. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1)
- Author
-
Bousquet, J. (Jean), Pham-Thi, N. (Nhân), Bedbrook, A. (Anna), Agache, I. (Ioana), Annesi-Maesano, I. (Isabella), Ansotegui, I.J. (I.), Anto, J.M. (Josep), Bachert, C. (Claus), Benveniste, S. (Samuel), Bewick, M. (Mike), Billo, N. (Nils), Bosnic-Anticevich, S. (Sinthia), Bosse, I. (Isabelle), Brusselle, G.G. (Guy), Calderon, M. (Moises), Canonica, G. (Gwalter), Caraballo, L.R. (L.), Cardona, D. (Doris), Carriazo, A.M. (Ana Maria), Cash, E. (Eugene), Cecchi, L. (Lorenzo), Chu, D.K. (Derek K.), Colgan, E. (Elaine), Costa, E. (Elisio), Cruz, A.A. (Alvaro), Czarlewski, W. (Wienczyslawa), Durham, S.R. (Stephen), Ebisawa, M. (Motohiro), Erhola, M. (Marina), Fauquert, J.-L. (Jean-Luc), Fokkens, W.J. (Wytske), Fonseca, J.A. (Joao A.), Guldemond, N. (Nick), Iinuma, T. (Tomohisa), Illario, M. (Maddalena), Klimek, L. (Ludger), Kuna, P. (Piotr), Kvedariene, V. (Violeta), Larenas-Linneman, D. (Désirée), Laune, D. (Daniel), Le, L.T.T. (Lan T.T.), Lourenço, O. (Olga), Malva, J.O. (Joao O.), Marien, G. (Gert), Menditto, E. (Enrica), Mullol, J. (Joaquim), Münter, L. (Lars), Okamoto, Y. (Yoshitaka), Onorato, G.L. (Gabrielle L.), Papadopoulos, N., Perala, M. (Maritta), Pfaar, O. (Oliver), Phillips, A. (Abigail), Phillips, J. (Jim), Pinnock, H. (Hilary), Portejoie, F. (Fabienne), Quinones-Delgado, P. (Pablo), Rolland, C. (Christine), Rodts, U. (Ulysse), Samolinski, B. (Boleslaw), Sanchez-Borges, M. (Mario), Schünemann, H.J. (Holger), Shamji, M. (Mohamed), Somekh, D. (David), Togias, A., Toppila-Salmi, S. (Sanna), Tsiligianni, I.G. (Ioanna G), Usmani, O. (Omar), Walker, S. (Samantha), Wallace, D. (D.), Valiulis, A. (Arunas), Van Der Kleij, R.M. (Rianne Mjj), Ventura, M.T. (Maria Teresa), Williams, S. (Sian), Yorgancioglu, A. (Arzu), Zuberbier, T. (Torsten), Bousquet, J. (Jean), Pham-Thi, N. (Nhân), Bedbrook, A. (Anna), Agache, I. (Ioana), Annesi-Maesano, I. (Isabella), Ansotegui, I.J. (I.), Anto, J.M. (Josep), Bachert, C. (Claus), Benveniste, S. (Samuel), Bewick, M. (Mike), Billo, N. (Nils), Bosnic-Anticevich, S. (Sinthia), Bosse, I. (Isabelle), Brusselle, G.G. (Guy), Calderon, M. (Moises), Canonica, G. (Gwalter), Caraballo, L.R. (L.), Cardona, D. (Doris), Carriazo, A.M. (Ana Maria), Cash, E. (Eugene), Cecchi, L. (Lorenzo), Chu, D.K. (Derek K.), Colgan, E. (Elaine), Costa, E. (Elisio), Cruz, A.A. (Alvaro), Czarlewski, W. (Wienczyslawa), Durham, S.R. (Stephen), Ebisawa, M. (Motohiro), Erhola, M. (Marina), Fauquert, J.-L. (Jean-Luc), Fokkens, W.J. (Wytske), Fonseca, J.A. (Joao A.), Guldemond, N. (Nick), Iinuma, T. (Tomohisa), Illario, M. (Maddalena), Klimek, L. (Ludger), Kuna, P. (Piotr), Kvedariene, V. (Violeta), Larenas-Linneman, D. (Désirée), Laune, D. (Daniel), Le, L.T.T. (Lan T.T.), Lourenço, O. (Olga), Malva, J.O. (Joao O.), Marien, G. (Gert), Menditto, E. (Enrica), Mullol, J. (Joaquim), Münter, L. (Lars), Okamoto, Y. (Yoshitaka), Onorato, G.L. (Gabrielle L.), Papadopoulos, N., Perala, M. (Maritta), Pfaar, O. (Oliver), Phillips, A. (Abigail), Phillips, J. (Jim), Pinnock, H. (Hilary), Portejoie, F. (Fabienne), Quinones-Delgado, P. (Pablo), Rolland, C. (Christine), Rodts, U. (Ulysse), Samolinski, B. (Boleslaw), Sanchez-Borges, M. (Mario), Schünemann, H.J. (Holger), Shamji, M. (Mohamed), Somekh, D. (David), Togias, A., Toppila-Salmi, S. (Sanna), Tsiligianni, I.G. (Ioanna G), Usmani, O. (Omar), Walker, S. (Samantha), Wallace, D. (D.), Valiulis, A. (Arunas), Van Der Kleij, R.M. (Rianne Mjj), Ventura, M.T. (Maria Teresa), Williams, S. (Sian), Yorgancioglu, A. (Arzu), and Zuberbier, T. (Torsten)
- Published
- 2019
- Full Text
- View/download PDF
6. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)
- Author
-
Bousquet, J. (Jean), Pham-Thi, N. (Nhân), Bedbrook, A. (Anna), Agache, I. (Ioana), Annesi-Maesano, I. (Isabella), Ansotegui, I.J. (I.), Anto, J.M. (Josep), Bachert, C. (Claus), Benveniste, S. (Samuel), Bewick, M. (Mike), Billo, N. (Nils), Bosnic-Anticevich, S. (Sinthia), Bosse, I. (Isabelle), Brusselle, G.G. (Guy), Calderon, M. (Moises), Canonica, G. (Gwalter), Caraballo, L.R. (L.), Cardona, D. (Doris), Carriazo, A.M. (Ana Maria), Cash, E. (Eugene), Cecchi, L. (Lorenzo), Chu, D.K. (Derek K.), Colgan, E. (Elaine), Costa, E. (Elisio), Cruz, A.A. (Alvaro), Czarlewski, W. (Wienczyslawa), Durham, S.R. (Stephen), Ebisawa, M. (Motohiro), Erhola, M. (Marina), Fauquert, J.-L. (Jean-Luc), Fokkens, W.J. (Wytske), Fonseca, J.A. (Joao A.), Guldemond, N. (Nick), Iinuma, T. (Tomohisa), Illario, M. (Maddalena), Klimek, L. (Ludger), Kuna, P. (Piotr), Kvedariene, V. (Violeta), Larenas-Linneman, D. (Désirée), Laune, D. (Daniel), Le, L.T.T. (Lan T.T.), Lourenço, O. (Olga), Malva, J.O. (Joao O.), Marien, G. (Gert), Menditto, E. (Enrica), Mullol, J. (Joaquim), Münter, L. (Lars), Okamoto, Y. (Yoshitaka), Onorato, G.L. (Gabrielle L.), Papadopoulos, N., Perala, M. (Maritta), Pfaar, O. (Oliver), Phillips, A. (Abigail), Phillips, J. (Jim), Pinnock, H. (Hilary), Portejoie, F. (Fabienne), Quinones-Delgado, P. (Pablo), Rolland, C. (Christine), Rodts, U. (Ulysse), Samolinski, B. (Boleslaw), Sanchez-Borges, M. (Mario), Schünemann, H.J. (Holger), Shamji, M. (Mohamed), Somekh, D. (David), Togias, A., Toppila-Salmi, S. (Sanna), Tsiligianni, I.G. (Ioanna G), Usmani, O. (Omar), Walker, S. (Samantha), Wallace, D. (D.), Valiulis, A. (Arunas), Van Der Kleij, R.M. (Rianne Mjj), Ventura, M.T. (Maria Teresa), Williams, S. (Sian), Yorgancioglu, A. (Arzu), Zuberbier, T. (Torsten), Bousquet, J. (Jean), Pham-Thi, N. (Nhân), Bedbrook, A. (Anna), Agache, I. (Ioana), Annesi-Maesano, I. (Isabella), Ansotegui, I.J. (I.), Anto, J.M. (Josep), Bachert, C. (Claus), Benveniste, S. (Samuel), Bewick, M. (Mike), Billo, N. (Nils), Bosnic-Anticevich, S. (Sinthia), Bosse, I. (Isabelle), Brusselle, G.G. (Guy), Calderon, M. (Moises), Canonica, G. (Gwalter), Caraballo, L.R. (L.), Cardona, D. (Doris), Carriazo, A.M. (Ana Maria), Cash, E. (Eugene), Cecchi, L. (Lorenzo), Chu, D.K. (Derek K.), Colgan, E. (Elaine), Costa, E. (Elisio), Cruz, A.A. (Alvaro), Czarlewski, W. (Wienczyslawa), Durham, S.R. (Stephen), Ebisawa, M. (Motohiro), Erhola, M. (Marina), Fauquert, J.-L. (Jean-Luc), Fokkens, W.J. (Wytske), Fonseca, J.A. (Joao A.), Guldemond, N. (Nick), Iinuma, T. (Tomohisa), Illario, M. (Maddalena), Klimek, L. (Ludger), Kuna, P. (Piotr), Kvedariene, V. (Violeta), Larenas-Linneman, D. (Désirée), Laune, D. (Daniel), Le, L.T.T. (Lan T.T.), Lourenço, O. (Olga), Malva, J.O. (Joao O.), Marien, G. (Gert), Menditto, E. (Enrica), Mullol, J. (Joaquim), Münter, L. (Lars), Okamoto, Y. (Yoshitaka), Onorato, G.L. (Gabrielle L.), Papadopoulos, N., Perala, M. (Maritta), Pfaar, O. (Oliver), Phillips, A. (Abigail), Phillips, J. (Jim), Pinnock, H. (Hilary), Portejoie, F. (Fabienne), Quinones-Delgado, P. (Pablo), Rolland, C. (Christine), Rodts, U. (Ulysse), Samolinski, B. (Boleslaw), Sanchez-Borges, M. (Mario), Schünemann, H.J. (Holger), Shamji, M. (Mohamed), Somekh, D. (David), Togias, A., Toppila-Salmi, S. (Sanna), Tsiligianni, I.G. (Ioanna G), Usmani, O. (Omar), Walker, S. (Samantha), Wallace, D. (D.), Valiulis, A. (Arunas), Van Der Kleij, R.M. (Rianne Mjj), Ventura, M.T. (Maria Teresa), Williams, S. (Sian), Yorgancioglu, A. (Arzu), and Zuberbier, T. (Torsten)
- Published
- 2019
- Full Text
- View/download PDF
7. Estimation du reste à charge pour les patients traités pour un lymphœdème primaire ou secondaire : une étude multicentrique nationale prospective
- Author
-
Quéré, I., primary, Pastor, J., additional, Clément, V., additional, Rodts, U., additional, Coupé, M., additional, Mestre, S., additional, Moffatt, C., additional, and Mercier, G., additional
- Published
- 2018
- Full Text
- View/download PDF
8. Healthcare Expenditures and Equity in Healthcare Utilization for Lymphedema Patients in France
- Author
-
Mercier, G, primary, Pastor, JZ, additional, Clement, V, additional, Rodts, U, additional, and Quere, I, additional
- Published
- 2016
- Full Text
- View/download PDF
9. PMD109 - Healthcare Expenditures and Equity in Healthcare Utilization for Lymphedema Patients in France
- Author
-
Mercier, G, Pastor, JZ, Clement, V, Rodts, U, and Quere, I
- Published
- 2016
- Full Text
- View/download PDF
10. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases -Meeting Report (Part 1)
- Author
-
Elaine Colgan, Mario Sánchez-Borges, Jim Phillips, Ignacio J. Ansotegui, Bolesław Samoliński, Olga Lourenço, Giorgio Walter Canonica, F. Portejoie, Isabella Annesi-Maesano, Gabrielle L. Onorato, Victoria Cardona, João O. Malva, Eugene Cash, Christine Rolland, Hilary Pinnock, Samantha Walker, Yoshitaka Okamoto, Ana Maria Carriazo, Lorenzo Cecchi, Nikos G. Papadopoulos, Jean Bousquet, L. T. T. Le, João Fonseca, Oliver Pfaar, Luis Caraballo, Elísio Costa, Maritta Perala, Pablo Quinones-Delgado, Torsten Zuberbier, Holger J. Schünemann, Tomohisa Iinuma, Enrica Menditto, Maddalena Illario, Nils E. Billo, Arunas Valiulis, Sinthia Bosnic-Anticevich, Josep M. Antó, Nick A. Guldemond, Maria Teresa Ventura, Claus Bachert, Wytske Fokkens, Lars Münter, Mohamed H. Shamji, Ioana Agache, Ulysse Rodts, Daniel Laune, Sanna Toppila-Salmi, Joaquim Mullol, Ioanna Tsiligianni, Motohiro Ebisawa, Isabelle Bosse, Samuel Benveniste, Arzu Yorgancioglu, Alkis Togias, M. Bewick, Nhân Pham-Thi, Stephen R. Durham, Moises A. Calderon, Marina Erhola, Violeta Kvedariene, Omar S. Usmani, Alvaro A. Cruz, Anna Bedbrook, Abigail Phillips, Desiree Larenas-Linneman, Guy Brusselle, Gert Marien, Dana Wallace, David Somekh, Sian Williams, Wienczyslawa Czarlewski, Ludger Klimek, Piotr Kuna, Jean-Luc Fauquert, Rianne van der Kleij, Derek K. Chu, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Service de Pneumologie Allergologie [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Pasteur [Paris], Transilvania University of Brasov, Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospital Quiròn Bizkaia Erandio, Universitat Pompeu Fabra [Barcelona] (UPF), CIBER de Epidemiología y Salud Pública (CIBERESP), Ghent University Hospital, Centre de Recherche en Informatique (CRI), MINES ParisTech - École nationale supérieure des mines de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL), AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], iQ4U consultants Ltd, University of Joensuu, The University of Sydney, Imperial College London, Humanitas Clinical and Research Center [Rozzano, Milan, Italy], Institute for Immunological Research (University of Cartagena), Vall d'Hebron University Hospital [Barcelona], Servicio Andaluz de Salud, Nova Southeastern University (NSU), Azienda Sanitaria di Prato, McMaster University [Hamilton, Ontario], DEPARTMENT OF HEALTH ( Social Services and Public Safety), Universidade do Porto, Universidade Federal da Bahia (UFBA), UCB Pharma, Colombes, Sagamihara National Hospital, National Institute for Health and Welfare [Helsinki], CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA), Faculdade de Medicina da Universidade do Porto (FMUP), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Chiba University Hospital, 'Federico II' University of Naples Medical School, Zentrum für Rhinologie und Allergologie [Wiesbaden, Germany], Medical University of Łódź (MUL), Vilnius University [Vilnius], Hospital Medica Sur [Mexico City, Mexico], KYomed INNOV, Ho Chi Minh City University of Technology (HCMUT), Faculty of Health Sciences and CICS-UB (Health Sciences Research Centre), University of Coimbra [Portugal] (UC), Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Department of Public Health [Copenhagen], Faculty of Health and Medical Sciences, University of Copenhagen = Københavns Universitet (KU)-University of Copenhagen = Københavns Universitet (KU), University of Manchester [Manchester], University of Athens Medical School [Athens], University of Oulu, Philipps University of Marburg, Cardiff University, University of Edinburgh, Regional Government for Equality, Medical University of Warsaw - Poland, Centro Medico-Docente La Trinidad, Department of Clinical Epidemiology and Biostatistics and Medicine, National Institute of Allergy and Infectious Diseases [Bethesda] (NIAID-NIH), National Institutes of Health [Bethesda] (NIH), University of Helsinki, University of Crete [Heraklion] (UOC), National Heart and Lung Institute [London] (NHLI), Imperial College London-Royal Brompton and Harefield NHS Foundation Trust, King's College Hospital (KCH), Leiden University Medical Center (LUMC), University of Bari Aldo Moro (UNIBA), Manisa Celal Bayar University, Humboldt-Universität zu Berlin, Association Asthme et Allergie, Health Services Management & Organisation (HSMO), University Hospital Montpellier, Montpellier, France, MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France, INSERM U 1168, VIMA, Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France, EUFOREA, Brussels, Belgium, Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany, Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany, Allergy Department, Pasteur Institute, Paris, France, Faculty of Medicine, Transylvania University, Brasov, Romania, Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Universités, Medical School Saint Antoine, Paris, France, Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain, ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Universitat Pompeu Fabra (UPF), Barcelona, Spain, CIBER Epidemiolog a y Salud Pública (CIBERESP), Barcelona, Spain, Upper Airways Research Laboratory, ENT Dept., Ghent University Hospital, Ghent, Belgium, National Center of Expertise in Cognitive Stimulation (CEN STIMCO), Broca Hospital, Paris, France, Mines ParisTech CRI - PSL Research University, Fontainebleau, France, iQ4U Consultants Ltd., London, United Kingdom, Joensuu, Finland, Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, NSW, Australia, La Rochelle, France, Dept. of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium, Imperial College London, National Heart and Lung Institute, London, United Kingdom, Personalized Medicine Clinic Asthma and Allergy, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy, Institute for Immunological Research, University of Cartagena, Campus de Zaragocilla, Edificio Biblioteca Primer piso, Cartagena, Colombia, Foundation for the Development of Medical and Biological Sciences (Fundemeb), Cartagena, Colombia, Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron and ARADyAL Research Network, Barcelona, Spain, Regional Ministry of Health of Andalusia, Seville, Spain, College of Psychology, Nova Southeastern University, School-related Psychological Assessments and Clinical Interventions Clinic, Ft Lauderdale, FL, United States, SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy, Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, Canada, Department of Health, Social Services and Public Safety, Belfast, United Kingdom, UCIBIO, REQUIMTE, Faculty of Pharmacy, Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, Porto, Portugal, ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, Brasil and WHO GARD Executive Committee, Bahia, Brazil, Medical Consulting Czarlewski, Levallois, France, Allergy and Clinical Immunology Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan, National Institute for Health and Welfare, Helsinki, Finland, CHU Clermont-Ferrand, Unité d’Allergologie de l’Enfant, Pôle Pédiatrique, Hôpital Estaing, Clermont-Ferrand, France, Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, Netherlands, CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina, Universidade do Porto, Medida, Lda, Porto, Portugal, Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, Netherlands, Dept. of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan, Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R and D and DISMET), Naples, Italy, Center for Rhinology and Allergology, Wiesbaden, Germany, Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland, Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania, Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine, Vilnius, Lithuania, Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico, KYomed INNOV, Montpellier, France, University of Medicine and Pharmacy, Hochiminh City, Viet Nam, Faculty of Health Sciences, CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal, CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy, Rhinology Unit and Smell Clinic, ENT Department, Hospital Cl nic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain, Danish Committee for Health Education, Copenhagen East, Denmark, Division of Infection, Immunity and Respiratory Medicine, Royal Manchester Children’s Hospital, University of Manchester, Manchester, United Kingdom, Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital 'P and A Kyriakou', University of Athens, Athens, Greece, University of Oulu, Faculty of Medicine, Oulun Yliopisto, Finland, Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Germany, Department of Health and Social Services, Welsh Government, Cardiff, United Kingdom, Centre For Empowering Patients and Communities, Dublin, Ireland, Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom, Agency for Social Services and Dependency, Regional Government for Equality, Social Policies and Conciliation of Andalucia, Seville, Spain, Association Asthme et Allergie, Paris, France, KanopyMed, Paris, France, Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland, Allergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela, Immunomodulation and Tolerance Group, Imperial College London, London, United Kingdom, Allergy and Clinical Immunology, Imperial College London, London, United Kingdom, European Health Futures Forum (EHFF), Dromahair, Ireland, Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States, Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland, Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Crete, Greece, International Primary Care Respiratory Group IPCRG, Aberdeen, United Kingdom, National Heart and Lung Institute (NHLI), Imperial College London, Royal Brompton Hospital, Airways Disease Section, London, United Kingdom, Asthma UK, London, United Kingdom, Nova Southeastern University, Fort Lauderdale, FL, United States, Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, Institute of Health Sciences, Vilnius, Lithuania, Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands, University of Bari Medical School, Unit of Geriatric Immunoallergology, Bari, Italy, Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa, Turkey, Universitätsmedizin Berlin, Humboldt-Uniersität zu Berlin, Berlin, Germany, Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, Berlin, Germany, uBibliorum, Ear, Nose and Throat, AII - Inflammatory diseases, Institut Pasteur [Paris] (IP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Hospital Quirónsalud Bizkaia [Bilbao], Mines Paris - PSL (École nationale supérieure des mines de Paris), Universidade do Porto = University of Porto, Sagamihara National Hospital [Kanagawa, Japan], University of Copenhagen = Københavns Universitet (UCPH)-University of Copenhagen = Københavns Universitet (UCPH), Philipps Universität Marburg = Philipps University of Marburg, Centro Médico Docente La Trinidad, Helsingin yliopisto = Helsingfors universitet = University of Helsinki, Università degli studi di Bari Aldo Moro = University of Bari Aldo Moro (UNIBA), Humboldt University Of Berlin, Salvy-Córdoba, Nathalie, Universiteit Leiden, Bousquet, J., Pham-Thi, N., Bedbrook, A., Agache, I., Annesi-Maesano, I., Ansotegui, I., Anto, J. M., Bachert, C., Benveniste, S., Bewick, M., Billo, N., Bosnic-Anticevich, S., Bosse, I., Brusselle, G., Calderon, M. A., Canonica, G. W., Caraballo, L., Cardona, V., Carriazo, A. M., Cash, E., Cecchi, L., Chu, D. K., Colgan, E., Costa, E., Cruz, A. A., Czarlewski, W., Durham, S., Ebisawa, M., Erhola, M., Fauquert, J. -L., Fokkens, W. J., Fonseca, J. A., Guldemond, N., Iinuma, T., Illario, M., Klimek, L., Kuna, P., Kvedariene, V., Larenas-Linneman, D., Laune, D., Le, L. T. T., Lourenco, O., Malva, J. O., Marien, G., Menditto, E., Mullol, J., Munter, L., Okamoto, Y., Onorato, G. L., Papadopoulos, N. G., Perala, M., Pfaar, O., Phillips, A., Phillips, J., Pinnock, H., Portejoie, F., Quinones-Delgado, P., Rolland, C., Rodts, U., Samolinski, B., Sanchez-Borges, M., Schunemann, H. J., Shamji, M., Somekh, D., Togias, A., Toppila-Salmi, S., Tsiligianni, I., Usmani, O., Walker, S., Wallace, D., Valiulis, A., Van Der Kleij, R., Ventura, M. T., Williams, S., Yorgancioglu, A., and Zuberbier, T.
- Subjects
Pulmonary and Respiratory Medicine ,Allergy ,medicine.medical_specialty ,Allergic and chronic respiratory diseases ,[SDV.IMM] Life Sciences [q-bio]/Immunology ,Allergic rhinitis - Asthma - Multimorbidity ,Health care system ,Health literacy ,03 medical and health sciences ,0302 clinical medicine ,SDG 3 - Good Health and Well-being ,Health care ,medicine ,Patient participation ,mHealth ,Asthma ,Rhinitis ,[SDV.EE]Life Sciences [q-bio]/Ecology, environment ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,Newsletter of GARD Section ,business.industry ,Environmental exposure ,medicine.disease ,3. Good health ,Integrated care ,[SDV.EE] Life Sciences [q-bio]/Ecology, environment ,030228 respiratory system ,13. Climate action ,Family medicine ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,030211 gastroenterology & hepatology ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
International audience; In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system for integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) (2), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life integrated care pathways (ICPs) (3)-centred around the patient with rhinitis and using mHealth monitoring of environmental exposure (4).An expert meeting took place at the Pasteur Institute in Paris, December 3, 2018. The aim was to discuss next-generation care pathways: (I) Patient participation, health literacy and self-care through technology-assisted “patient activation”; (II) Implementation of care pathways by pharmacists and (III) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) assessed by mobile technology.The EU (5) and global political agendas are of great importance in supporting health care transformation. MASK has been recognized by DG Santé as a Good Practice (6) in the field of digitally-enabled, integrated, person-centred care.The one-day meeting objectives were clear (Figure 1). The meeting was followed by a workshop. The present paper reports the background of the two-day meeting.
- Published
- 2019
11. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)
- Author
-
Josep M. Antó, Nick A. Guldemond, Ulysse Rodts, Bolesław Samoliński, Olga Lourenço, Mohamed H. Shamji, Tomohisa Iinuma, Rianne van der Kleij, Alkis Togias, W. J. Fokkens, Gert Marien, Derek K. Chu, Mario Sánchez-Borges, Daniel Laune, Desiree Larenas-Linneman, Anna Bedbrook, Guy Brusselle, Joaquim Mullol, Lars Münter, Ludger Klimek, Sanna Toppila-Salmi, Eugene Cash, Christine Rolland, Ioanna Tsiligianni, Isabelle Bosse, Dana Wallace, Motohiro Ebisawa, Abigail Phillips, Torsten Zuberbier, G. Walter Canonica, Elísio Costa, Samuel Benveniste, Yoshitaka Okamoto, Holger J. Schünemann, Moises A. Calderon, Sinthia Bosnic-Anticevich, Mike Bewick, Elaine Colgan, Arunas Valiulis, Sian Williams, Samantha Walker, Ignacio J. Ansotegui, David Somekh, Isabella Annesi-Maesano, Victoria Cardona, Wienczyslawa Czarlewski, Claus Bachert, Ana Maria Carriazo, João Fonseca, Nils Billo, Violeta Kvedariene, Ioana Agache, Maria Teresa Ventura, Jim Phillips, Piotr Kuna, Hilary Pinnock, Lorenzo Cecchi, F. Portejoie, Jean-Luc Fauquert, Alvaro A. Cruz, Jean Bousquet, Nikos Papadopoulos, Omar S. Usmani, Gabrielle L. Onorato, Arzu Yorgancioglu, Pablo Quinones-Delgado, Oliver Pfaar, Luis Caraballo, Stephen R. Durham, L. T. T. Le, João O. Malva, Maritta Perala, Enrica Menditto, Nhân Pham-Thi, Marina Erhola, Maddalena Illario, Ear, Nose and Throat, AII - Inflammatory diseases, University Hospital Montpellier, Montpellier, France, MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France, INSERM U1168, VIMA, Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France, Université Versailles St-Quentin-en Yvelines, UMR-S 1168, Montigny le Bretonneux, France, Euforea, Brussels, Belgium, Charité, Universitätsmedizin Berlin, Humboldt-Universitätzu Berlin, Berlin, Germany, Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany, EUFOREA, Brussels, Belgium, Allergy Department, Pasteur Institute, Paris, France, Faculty of Medicine, Transylvania University, Brasov, Romania, Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM and Sorbonne Universités, Medical School Saint Antoine, Paris, France, Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain, ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Universitat Pompeu Fabra (UPF), Barcelona, Spain, CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain, Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium, National Center of Expertise in Cognitive Stimulation (CEN STIMCO), Broca Hospital, Paris, France, Mines ParisTech CRI - PSL Research University, Fontainebleau, France, iQ4U Consultants Ltd, London, United Kingdom, Independent Consultant, Joensuu, Finland, Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, NSW, Australia, Allergist, La Rochelle, France, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium, Imperial College London-National Heart and Lung Institute, London, United Kingdom, Personalized Medicine Clinic Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano (MI), Italy, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy, Institute for Immunological Research, University of Cartagena, Campus de Zaragocilla, Edificio Biblioteca Primer piso, Cartagena, Colombia, Foundation for the Development of Medical and Biological Sciences, Cartagena, Colombia, Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron and ARADyAL research network, Barcelona, Spain, Regional Ministry of Health of Andalusia, Seville, Spain, College of Psychology, Nova Southeastern University, School-related Psychological Assessments and Clinical Interventions Clinic, Ft Lauderdale, FL, United States, SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy, Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, Canada, Department of Health, Social Services and Public Safety, Northern Ireland, Belfast, United Kingdom, UCIBIO, REQUIMTE, Faculty of Pharmacy, and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, Porto, Portugal, ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, Brasil and WHO GARD Executive Committee, Bahia, Brazil, Medical Consulting Czarlewski, Levallois, France, Allergy and Clinical Immunology Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan, National Institute for Health and Welfare, Helsinki, Finland, CHU Clermont-Ferrand, Unité d’Allergologie de l’Enfant, Pôle Pédiatrique, Hôpital Estaing, Clermont-Ferrand, France, Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, Netherlands, CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, Medida, Lda Porto, Portugal, Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, Netherlands, Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan, Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R and D and DISMET), Naples, Italy, Center for Rhinology and Allergology, Wiesbaden, Germany, Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland, Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Institute of Clinical Medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius, Lithuania, Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico, KYomed INNOV, Montpellier, France, University of Medicine and Pharmacy, Hochiminh City, Viet Nam, Faculty of Health Sciences and CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal, CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy, Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain, Danish Committee for Health Education, Copenhagen East, Denmark, Division of Infection, Immunity and Respiratory Medicine, Royal Manchester Children’s Hospital, University of Manchester, Manchester, United Kingdom, Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital 'P and A Kyriakou', University of Athens, Athens, Greece, University of Oulu, Faculty of Medicine, Oulun Yliopisto, Finland, Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Germany, Department of Health and Social Services, Welsh Government, Cardiff, United Kingdom, Centre For Empowering Patients and Communities, Dublin, Ireland, Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, The, University of Edinburgh, Edinburgh, United Kingdom, Agency for Social Services and Dependency, Regional Government for Equality, Social Policies and Conciliation of Andalucia, Seville, Spain, Association Asthme et Allergie, Paris, France, KanopyMed, Paris, France, Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland, Allergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela, Immunomodulation and Tolerance Group, Imperial College London, and, Allergy and Clinical Immunology, Imperial College London, London, United Kingdom, European Health Futures Forum (EHFF), Dromahair, Ireland, Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States, Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland, Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Crete, Greece, International Primary Care Respiratory Group IPCRG, Aberdeen, United Kingdom, National Heart and Lung Institute (NHLI), Imperial College London, Royal Brompton Hospital, Airways Disease Section, London, United Kingdom, Asthma UK, London, United Kingdom, Nova Southeastern University, Fort Lauderdale, FL, United States, Vilnius University Faculty of Medicine, Institute of Clinical Medicine, Institute of Health Sciences, Vilnius, Lithuania, Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands, University of Bari Medical School, Unit of Geriatric Immunoallergology, Bari, Italy, Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa, Turkey, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, Berlin, Germany, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier Cedex 5, 34295, France, [Bousquet, Jean] Univ Hosp Montpellier, Montpellier, France, [Bousquet, Jean] Fdn Partenariale FMC VIA LR, MACVIA France, Montpellier, France, [Bedbrook, Anna] Fdn Partenariale FMC VIA LR, MACVIA France, Montpellier, France, [Onorato, Gabrielle L.] Fdn Partenariale FMC VIA LR, MACVIA France, Montpellier, France, [Portejoie, Fabienne] Fdn Partenariale FMC VIA LR, MACVIA France, Montpellier, France, [Bousquet, Jean] INSERM, Ageing & Chron Dis Epidemiol & Publ Hlth Approach, VIMA, U1168, Villejuif, France, [Bousquet, Jean] Univ Versailles St Quentin En Yvelines, UMR S 1168, Montigny Le Bretonneux, France, [Bousquet, Jean] Euforea, Brussels, Belgium, [Fokkens, Wytske J.] Euforea, Brussels, Belgium, [Marien, Gert] Euforea, Brussels, Belgium, [Bousquet, Jean] Humboldt Univ, Univ Med Berlin, Charite, Berlin, Germany, [Bousquet, Jean] Berlin Inst Hlth, Comprehens Allergy Ctr, Dept Dermatol & Allergy, Berlin, Germany, [Zuberbier, Torsten] Berlin Inst Hlth, Comprehens Allergy Ctr, Dept Dermatol & Allergy, Berlin, Germany, [Nhan Pham-Thi] Pasteur Inst, Allergy Dept, Paris, France, [Agache, Ioana] Transylvania Univ, Fac Med, Brasov, Romania, [Annesi-Maesano, Isabella] INSERM, Depet Inst Pierre Louis Epidemiol & Publ, Epidemiol Allerg & Resp Dis, Paris, France, [Annesi-Maesano, Isabella] Sorbonne Univ, Med Sch St Antoine, Paris, France, [Ansotegui, Ignacio] Hosp Quironsalud Bizkaia, Dept Allergy & Immunol, Erandio, Spain, [Anto, Josep M.] Ctr Res Environm Epidemiol CREAL, ISGlobAL, Barcelona, Spain, [Anto, Josep M.] Univ Pompeu Fabra, Barcelona, Spain, [Anto, Josep M.] CIBERESP, Barcelona, Spain, [Bachert, Claus] Ghent Univ Hosp, ENT Dept, Upper Airways Res Lab, Ghent, Belgium, [Benveniste, Samuel] Broca Hosp, Natl Ctr Expertise Cognit Stimulat CEN STIMCO, Paris, France, [Benveniste, Samuel] PSL Res Univ, Mines ParisTech CRI, Fontainebleau, France, [Bewick, Mike] iQ4U Consultants Ltd, London, England, [Bosnic-Anticevich, Sinthia] Univ Sydney, Woolcock Inst Med Res, Glebe, NSW, Australia, [Bosnic-Anticevich, Sinthia] Woolcock Emphysema Ctr, Glebe, NSW, Australia, [Bosnic-Anticevich, Sinthia] Sydney Local Hlth Dist, Glebe, NSW, Australia, [Brusselle, Guy] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium, [Calderon, Moses A.] Imperial Coll London, Natl Heart & Lung Inst, London, England, [Usmani, Omar] Imperial Coll London, Natl Heart & Lung Inst, London, England, [Canonica, G. Walter] IRCCS, Humanitas Clin & Res Ctr, Personalized Med Clin Asthma & Allergy, Rozzano, MI, Italy, [Canonica, G. Walter] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, MI, Italy, [Caraballo, Luis] Univ Cartagena, Inst Immunol Res, Campus Zaragocilla, Cartagena, Colombia, [Caraballo, Luis] Fdn Dev Med & Biol Sci Fundemeb, Cartagena, Colombia, [Cardona, Victoria] Hosp Valle De Hebron, Dept Internal Med, Allergy Sect, Barcelona, Spain, [Cardona, Victoria] ARADyAL Res Network, Barcelona, Spain, [Maria Carriazo, Ana] Reg Minist Hlth Andalusia, Seville, Spain, [Cash, Eugene] Nova Southeastern Univ, Coll Psychol, Ft Lauderdale, FL 33314 USA, [Cash, Eugene] Sch Related Psychol Assessments & Clin Intervent, Ft Lauderdale, FL USA, [Cecchi, Lorenzo] USL Toscana Ctr, SOS Allergol & Clin Immunol, Prato, Italy, [Schunemann, Holger J.] USL Toscana Ctr, SOS Allergol & Clin Immunol, Prato, Italy, [Chu, Derek K.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Dept Med, Div Immunol & Allergy, Hamilton, ON, Canada, [Colgan, Elaine] Dept Hlth Social Serv & Publ Safety, Belfast, Antrim, North Ireland, [Costa, Elisio] Univ Porto, UCIBIO, Fac Pharm, REQUIMTE, Porto, Portugal, [Costa, Elisio] Univ Porto, AgeUPNetWork, Competence Ctr Act & Hlth Ageing, Porto, Portugal, [Cruz, Alvaro A.] Univ Fed Bahia, ProAR Nucleo Excelencia Asma, Salvador, BA, Brazil, [Cruz, Alvaro A.] WHO GARD Execut Comm, Salvador, BA, Brazil, [Czarlewski, Wienczyslawa] Med Consulting Czarlewski, Levallois Perret, France, [Durham, Stephen] Imperial Coll London, Natl Heart & Lung Inst, Allergy & Clin Immunol Sect, London, England, [Ebisawa, Motohiro] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan, [Erhola, Marina] Natl Inst Hlth & Welf, Helsinki, Finland, [Fauquert, Jean-Luc] CHU Clermont Ferrand, Hop Estaing, Pole Pediat, Unit Allergol Enfant, Clermont Ferrand, France, [Fokkens, Wytske J.] Amsterdam Univ Med Ctr, Dept Otorhinolaryngol, AMC, Amsterdam, Netherlands, [Fonseca, Joao A.] Univ Porto, Ctr Res Hlth Technol & Informat Syst, Fac Med, CINTESIS, Porto, Portugal, [Fonseca, Joao A.] Medida Lda, Porto, Portugal, [Guldemond, Nick] Erasmus Univ, Inst Hlth Policy & Management iBMG, Rotterdam, Netherlands, [Iinuma, Tomohisa] Chiba Univ Hosp, Dept Otorhinolaryngol, Chiba, Japan, [Okamoto, Yoshitaka] Chiba Univ Hosp, Dept Otorhinolaryngol, Chiba, Japan, [Illario, Maddalena] Campania Reg, Div Hlth Innovat, Naples, Italy, [Illario, Maddalena] Federico II Univ Hosp Naples, R&D, Naples, Italy, [Illario, Maddalena] Federico II Univ Hosp Naples, DISMET, Naples, Italy, [Klimek, Ludger] Ctr Rhinol & Allergol, Wiesbaden, Germany, [Kuna, Piotr] Med Univ Lodz, Barlicki Univ Hosp, Div Internal Med Asthma & Allergy, Lodz, Poland, [Kvedariene, Violeta] Vilnius Univ, Fac Med, Dept Pathol, Inst Biomed Sci, Vilnius, Lithuania, [Kvedariene, Violeta] Fac Med, Inst Clin Med, Clin Chest Dis & Allergol, Vilnius, Lithuania, [Larenas-Linneman, Desiree] Med Sur Clin Fdn & Hosp, Ctr Excellence Asthma & Allergy, Mexico City, DF, Mexico, [Laune, Daniel] KYomed INNOV, Montpellier, France, [Le, Lan T. T.] Univ Med & Pharm, Hochiminh City, Vietnam, [Lourenco, Olga] Univ Beira Interior, Fac Hlth Sci, Covilha, Portugal, [Lourenco, Olga] Univ Beira Interior, Hlth Sci Res Ctr, CICS UBI, Covilha, Portugal, [Malva, Joao O.] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal, [Malva, Joao O.] Ageing Coimbra EIP AHA Reference Site, Coimbra, Portugal, [Menditto, Enrica] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy, [Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Spain, [Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Spain, [Mullol, Joaquim] Univ Barcelona, CIBERES, IDIBAPS, Clin & Expt Resp Immunoallergy, Barcelona, Spain, [Munter, Lars] Danish Comm Hlth Educ, Copenhagen East, Denmark, [Papadopoulos, Nikos G.] Univ Manchester, Royal Manchester Childrens Hosp, Div Infect Immun & Resp Med, Manchester, Lancs, England, [Papadopoulos, Nikos G.] Univ Athens, Athens Gen Childrens Hosp P&A Kyriakou, Allergy Dept, Pediat Clin 2, Athens, Greece, [Perala, Maritta] Univ Oulu, Fac Med, Oulu, Finland, [Pfaar, Oliver] Phillipps Univ Marburg, Univ Hosp Marburg, Sect Rhinol & Allergy, Dept Otorhinolaryngol Head & Neck Surg, Marburg, Germany, [Phillips, Abigail] Welsh Govt, Dept Hlth & Social Serv, Cardiff, S Glam, Wales, [Phillips, Jim] Ctr Empowering Patients & Communities, Dublin, Ireland, [Pinnock, Hilary] Univ Edinburgh, Asthma UK Ctr Appl Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland, [Quinones-Delgado, Pablo] Agcy Social Serv & Dependency, Reg Govt Equal Social Policies & Conciliat Andalu, Seville, Spain, [Rolland, Christine] Assoc Asthme & Allergie, Paris, France, [Rodts, Ulysse] KanopyMed, Paris, France, [Samolinski, Boleslaw] Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland, [Sanchez-Borges, Mario] Ctr Medicodocente La Trinidad, Allergy & Clin Immunol Dept, Caracas, Venezuela, [Shamji, Mohamed] Imperial Coll London, Immunomodulat & Tolerance Grp, London, England, [Shamji, Mohamed] Imperial Coll London, Allergy & Clin Immunol, London, England, [Somekh, David] EHFF, Dromahair, Ireland, [Togias, Alkis] NIAID, DAIT, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA, [Toppila-Salmi, Sanna] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland, [Toppila-Salmi, Sanna] Univ Helsinki, Helsinki, Finland, [Tsiligianni, Ioanna] Univ Crete, Fac Med, Dept Social Med, Hlth Planning Unit, Iraklion, Greece, [Tsiligianni, Ioanna] Int Primary Care Resp Grp, Aberdeen, Scotland, [Williams, Sian] Int Primary Care Resp Grp, Aberdeen, Scotland, [Usmani, Omar] Royal Brompton Hosp, Airways Dis Sect, London, England, [Walker, Samantha] Asthma UK, London, England, [Wallace, Dana] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA, [Valiulis, Arunas] Vilnius Univ, Inst Clin Med, Fac Med, Vilnius, Lithuania, [Valiulis, Arunas] Inst Hlth Sci, Vilnius, Lithuania, [Van der Kleij, Rianne] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands, [Ventura, Maria Teresa] Univ Bari, Unit Geriatr Immunoallergol, Med Sch, Bari, Italy, [Yorgancioglu, Arzu] Celal Bayar Univ, Fac Med, Dept Pulm Dis, Manisa, Turkey, [Zuberbier, Torsten] Univ Med Berlin, Berlin, Germany, [Zuberbier, Torsten] Free Univ Berlin, Berlin, Germany, [Zuberbier, Torsten] Humboldt Uniersitat Berlin, Berlin, Germany, [Zuberbier, Torsten] GA2LEN, Berlin, Germany, Mylan, GSK, ALK, Novartis, Sanofi, Stallergenes-Greer, Uriach, Health Services Management & Organisation (HSMO), Bousquet, J., Pham-Thi, N., Bedbrook, A., Agache, I., Annesi-Maesano, I., Ansotegui, I., Anto, J. M., Bachert, C., Benveniste, S., Bewick, M., Billo, N., Bosnic-Anticevich, S., Bosse, I., Brusselle, G., Calderon, M. A., Canonica, G. W., Caraballo, L., Cardona, V., Carriazo, A. M., Cash, E., Cecchi, L., Chu, D. K., Colgan, E., Costa, E., Cruz, A. A., Czarlewski, W., Durham, S., Ebisawa, M., Erhola, M., Fauquert, J. -L., Fokkens, W. J., Fonseca, J. A., Guldemond, N., Iinuma, T., Illario, M., Klimek, L., Kuna, P., Kvedariene, V., Larenas-Linneman, D., Laune, D., Le, L. T. T., Lourenco, O., Malva, J. O., Marien, G., Menditto, E., Mullol, J., Munter, L., Okamoto, Y., Onorato, G. L., Papadopoulos, N. G., Perala, M., Pfaar, O., Phillips, A., Phillips, J., Pinnock, H., Portejoie, F., Quinones-Delgado, P., Rolland, C., Rodts, U., Samolinski, B., Sanchez-Borges, M., Schunemann, H. J., Shamji, M., Somekh, D., Togias, A., Toppila-Salmi, S., Tsiligianni, I., Usmani, O., Walker, S., Wallace, D., Valiulis, A., Van der Kleij, R., Ventura, M. T., Williams, S., Yorgancioglu, A., Zuberbier, T., and uBibliorum
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,Allergy ,medicine.medical_specialty ,Aria ,Allergic rhinitis - Asthma - Multimorbidity ,Health literacy ,Chronic respiratory-diseases ,03 medical and health sciences ,0302 clinical medicine ,SDG 3 - Good Health and Well-being ,Health care ,medicine ,Self-management ,Global alliance ,Intensive care medicine ,mHealth ,Asthma ,Newsletter of GARD Section ,business.industry ,Environmental exposure ,medicine.disease ,3. Good health ,Integrated care ,030104 developmental biology ,Impact ,030228 respiratory system ,13. Climate action ,business - Abstract
In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative (2), and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) (3), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs—centred around the patient with rhinitis and using mHealth monitoring of environmental exposure. An expert meeting took place at the Pasteur Institute in Paris, December 3, 2018. The aim was to discuss nextgeneration care pathways following an ongoing political agenda (4,5): (I) patient participation, health literacy and self-care through technology-assisted “patient activation”; (II) implementation of care pathways by pharmacists and (III) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) assessed by mobile technology. The present document reviews the workshop report and follows on from Part 1.
- Published
- 2019
12. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).
- Author
-
Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, and Zuberbier T
- Abstract
Competing Interests: Conflicts of Interest: Dr. Ansotegui reports personal fees from Mundipharma, Roxall, Sanofi, MSD, Faes Farma, Hikma, UCB, Astra Zeneca, outside the submitted work. Dr. Bachert reports personal fees from ALK, Stallergen, during the conduct of the study; personal fees from ALK, Stallergen, outside the submitted work. Dr. Bousquet reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi-Aventis, Takeda, Teva, Uriach, other from KYomed-Innov, outside the submitted work. Dr. Calderon reports personal fees from ALK-Abello, ALK-US, Stallergenes Greer, HAL-Allergy, Allergopharma, ASIT-Biotech, outside the submitted work. Dr. Canonica reports grants from ALK ABELLO, Allergy Therapeutics, Anallergo, Hal Allergy, Stallergenes Greer, outside the submitted work. Dr. Cardona reports personal fees from ALK, Allergopharma, Allergy Therapeutics, Diater, LETI, Thermofisher, Stallergenes, outside the submitted work. Dr. Cecchi reports personal fees from Menarini, Malesci ALK, outside the submitted work. Dr. Cruz reports grants from National Institutes for Health Research (UK), National Institutes of Health (USA), grants and other from National Research Council (Brazil), other from Federal University of Bahia (Brazil), non-financial support from Fundacao ProAR, grants and personal fees from GSK, personal fees from AstraZeneca, Boehringer Ingelheim, CHIESI, Eurofarma, MEDA Pharma. Dr. Durham reports personal fees from Adiga, personal fees from ALK, personal fees from Allergopharma, MedicalUpdate GmBC, UCB, outside the submitted work. Dr. Ebisawa reports personal fees from Mylan, DBV Technologies, Thermofisher, outside the submitted work. Dr. Fokkens reports grants from Mylan, Allergy Therapeutics, GSK, ALK. Dr. Fonseca being a partner in a company developing mobile technologies for monitoring airways diseases. Dr. Klimek reports grants and personal fees from ALK Abelló, Denmark, grants and personal fees from Novartis, Switzerland, Allergopharma, Germany, Bionorica, Sweden, GSK, Great Britain, Lofarma, Italy, personal fees from MEDA, Sweden, Boehringer Ingelheim, Germany, grants from Biomay, Austria, grants from HAL, Netherlands, grants from LETI, Spain, Roxall, Germany, Bencard, Great Britain, outside the submitted work. Dr. Kuna reports personal fees from Adamed, AstraZeneca, Boehringer Ingelheim, Hal, Chiesi, Novartis, Berlin Chemie Menarini, outside the submitted work. Dr. Kvedariene reports personal fees from GSK, non-financial support from StallergenGreer, Mylan, AstraZeneca, Dimuna, Norameda, outside the submitted work. D Larenas Linnemann reports personal fees from GSK, Astrazeneca, MEDA, Boehringer Ingelheim, Novartis, Grunenthal, UCB, Amstrong, Siegfried, DBV Technologies, MSD, Pfizer. grants from Sanofi, Astrazeneca, Novartis, UCB, GSK, TEVA, Chiesi, Boehringer Ingelheim, outside the submitted work. Dr. MULLOL reports personal fees from SANOFI-GenzymeRegeneron, ALK-Abelló A/S, Menarini Group, MSD, GlaxoSmithKline, Novartis, GENENTECH-Roche, grants and personal fees from UCB Pharma, MYLAN-MEDA Pharma, URIACH Group, outside the submitted work. Y Okamoto reports personal fees from Shionogi Co. Ltd., Torii Co. Ltd., GSK, MSD, Kyowa Co. Ltd., from Eizai Co. Ltd., grants and personal fees from Kyorin Co. Ltd., Tiho Co. Ltd., grants from Yakuruto Co. Ltd., Yamada Bee Farm, outside the submitted work. N Papadopoulos reports personal fees from Novartis, Faes Farma, BIOMAY, HAL, Nutricia Research, Menarini, Novartis, MEDA, Abbvie, Novartis, MSD, Omega Pharma Danone, grants from Menarini outside the submitted work. O Pfaar reports grants and personal fees from ALK-Abelló, Allergopharma, Stallergenes Greer, HAL Allergy Holding B.V./HAL Allergie GmbH, Bencard Allergie GmbH/Allergy Therapeutics, Lofarma, Biotech Tools S.A, LETI/LETI Pharma, Anergis S.A. grants from Biomay, Nuvo, Circassia, Glaxo Smith Kline, personal fees from Novartis Pharma, MEDA Pharma, Mobile Chamber Experts (a GA2LEN Partner), Pohl-Boskamp, Indoor Biotechnologies, grants from, outside the submitted work. Dr. Samolinski reports non-financial support from Mylan, during the conduct of the study. Dr. Shamji reports grants and personal fees from ALK, ASIT Biotech, sa, Allergopharma, grants from Regeneron, Merck, Immune Tolerance Network, outside the submitted work. Dr. Tsiligianni reports personal fees from Novartis, GSK, Boehringer Ingelheim, Astra Zeneca, grants from GSK Hellas, outside the submitted work. Dr. Wallace is co-chair of the Joint Task Force on Practice Parameters of the AAAAI/ACAAI. However, it does not feel that this causes any conflict of interest in the writing/review of the document. Zuberbier reports fees from Bayer Health Care, FAES, Novartis, Henkel, Astra Zeneca, AbbVie, ALK, Almirrall, Astellas, Bayer Health Care, Bencard, Berlin Chemie, HAL, Leti, Meda, Menarini, Merck, MSD, Pfizer, Sanofi, Stallergenes, Takeda, Teva, UCB, Henkel, Kryolan, l’Oreal; Commitee member: WHO-Initiative “Allergic Rhinitis and Its Impact on Asthma” (ARIA). Member of the Board: German Society for Allergy and Clinical Immunology (DGAKI). Head: European Centre for Allergy Research Foundation (ECARF). Secretary General: Global Allergy and Asthma European Network (GA2LEN). Member: Committee on Allergy Diagnosis and Molecular Allergology, World Allergy Organization (WAO). The other authors have no conflicts of interest to declare.
- Published
- 2019
- Full Text
- View/download PDF
13. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).
- Author
-
Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, and Zuberbier T
- Abstract
Competing Interests: Conflicts of Interest: Dr. Ansotegui reports personal fees from Mundipharma, Roxall, Sanofi, MSD, Faes Farma, Hikma, UCB, Astra Zeneca, outside the submitted work. Dr. Bachert reports personal fees from ALK, Stallergen, during the conduct of the study; personal fees from ALK, Stallergen, outside the submitted work. Dr. Bousquet reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi-Aventis, Takeda, Teva, Uriach, other from KYomed-Innov, outside the submitted work. Dr. Calderon reports personal fees from ALK-Abello, ALK-US, Stallergenes Greer, HAL-Allergy, Allergopharma, ASIT-Biotech, outside the submitted work. Dr. Canonica reports grants from ALK ABELLO, Allergy Therapeutics, Anallergo, Hal Allergy, Stallergenes Greer, outside the submitted work. Dr. Cardona reports personal fees from ALK, Allergopharma, Allergy Therapeutics, Diater, LETI, Thermofisher, Stallergenes, outside the submitted work. Dr. Cecchi reports personal fees from Menarini, Malesci ALK, outside the submitted work. Dr. Cruz reports grants from National Institutes for Health Research (UK), National Institutes of Health (USA), grants and other from National Research Council (Brazil), other from Federal University of Bahia (Brazil), non-financial support from Fundacao ProAR, grants and personal fees from GSK, personal fees from AstraZeneca, Boehringer Ingelheim, CHIESI, Eurofarma, MEDA Pharma. Dr. Durham reports personal fees from Adiga, personal fees from ALK, personal fees from Allergopharma, MedicalUpdate GmBC, UCB, outside the submitted work. Dr. Ebisawa reports personal fees from Mylan, DBV Technologies, Thermofisher, outside the submitted work. Dr. Fokkens reports grants from Mylan, Allergy Therapeutics, GSK, ALK. Dr. Fonseca being a partner in a company developing mobile technologies for monitoring airways diseases. Dr. Klimek reports grants and personal fees from ALK Abelló, Denmark, grants and personal fees from Novartis, Switzerland, Allergopharma, Germany, Bionorica, Sweden, GSK, Great Britain, Lofarma, Italy, personal fees from MEDA, Sweden, Boehringer Ingelheim, Germany, grants from Biomay, Austria, grants from HAL, Netherlands, grants from LETI, Spain, Roxall, Germany, Bencard, Great Britain, outside the submitted work. Dr. Kuna reports personal fees from Adamed, AstraZeneca, Boehringer Ingelheim, Hal, Chiesi, Novartis, Berlin Chemie Menarini, outside the submitted work. Dr. Kvedariene reports personal fees from GSK, non-financial support from StallergenGreer, Mylan, AstraZeneca, Dimuna, Norameda, outside the submitted work. D Larenas Linnemann reports personal fees from GSK, Astrazeneca, MEDA, Boehringer Ingelheim, Novartis, Grunenthal, UCB, Amstrong, Siegfried, DBV Technologies, MSD, Pfizer. grants from Sanofi, Astrazeneca, Novartis, UCB, GSK, TEVA, Chiesi, Boehringer Ingelheim, outside the submitted work. Dr. MULLOL reports personal fees from SANOFI-Genzyme-Regeneron, ALK-Abelló A/S, Menarini Group, MSD, GlaxoSmithKline, Novartis, GENENTECH-Roche, grants and personal fees from UCB Pharma, MYLAN-MEDA Pharma, URIACH Group, outside the submitted work. Y Okamoto reports personal fees from Shionogi Co. Ltd., Torii Co. Ltd., GSK, MSD, Kyowa Co. Ltd., from Eizai Co. Ltd., grants and personal fees from Kyorin Co. Ltd., Tiho Co. Ltd., grants from Yakuruto Co. Ltd., Yamada Bee Farm, outside the submitted work. N Papadopoulos reports personal fees from Novartis, Faes Farma, BIOMAY, HAL, Nutricia Research, Menarini, Novartis, MEDA, Abbvie, Novartis, MSD, Omega Pharma Danone, grants from Menarini outside the submitted work. O Pfaar reports grants and personal fees from ALK-Abelló, Allergopharma, Stallergenes Greer, HAL Allergy Holding B.V./HAL Allergie GmbH, Bencard Allergie GmbH/Allergy Therapeutics, Lofarma, Biotech Tools S.A, LETI/LETI Pharma, Anergis S.A. grants from Biomay, Nuvo, Circassia, Glaxo Smith Kline, personal fees from Novartis Pharma, MEDA Pharma, Mobile Chamber Experts (a GA2LEN Partner), Pohl-Boskamp, Indoor Biotechnologies, grants from, outside the submitted work. Dr. Samolinski reports non-financial support from Mylan, during the conduct of the study. Dr. Shamji reports grants and personal fees from ALK, ASIT Biotech, sa, Allergopharma, grants from Regeneron, Merck, Immune Tolerance Network, outside the submitted work. Dr. Tsiligianni reports personal fees from Novartis, GSK, Boehringer Ingelheim, Astra Zeneca, grants from GSK Hellas, outside the submitted work. Dr. Wallace is co-chair of the Joint Task Force on Practice Parameters of the AAAAI/ACAAI. However, it does not feel that this causes any conflict of interest in the writing/review of the document. Zuberbier reports fees from Bayer Health Care, FAES, Novartis, Henkel, Astra Zeneca, AbbVie, ALK, Almirrall, Astellas, Bayer Health Care, Bencard, Berlin Chemie, HAL, Leti, Meda, Menarini, Merck, MSD, Pfizer, Sanofi, Stallergenes, Takeda, Teva, UCB, Henkel, Kryolan, l’Oreal; Commitee member: WHO-Initiative “Allergic Rhinitis and Its Impact on Asthma” (ARIA). Member of the Board: German Society for Allergy and Clinical Immunology (DGAKI). Head: European Centre for Allergy Research Foundation (ECARF). Secretary General: Global Allergy and Asthma European Network (GA2LEN). Member: Committee on Allergy Diagnosis and Molecular Allergology, World Allergy Organization (WAO). The other authors have no conflicts of interest to declare.
- Published
- 2019
- Full Text
- View/download PDF
14. Out-of-pocket payments, vertical equity and unmet medical needs in France: A national multicenter prospective study on lymphedema.
- Author
-
Mercier G, Pastor J, Clément V, Rodts U, Moffat C, and Quéré I
- Subjects
- Adult, Aged, Female, Follow-Up Studies, France, Humans, Male, Middle Aged, Prospective Studies, Health Expenditures, Insurance, Health, Lymphedema economics, Lymphedema therapy, Socioeconomic Factors
- Abstract
Out-of-pocket payments might threaten the vertical equity of financing and generate unmet medical needs. The main objective was to assess the vertical equity of outpatient out-of-pocket payments for lymphedema patients in France. Twenty-seven centres, among which 11 secondary care hospitals and 16 primary care practices participated in this prospective national multicenter study. We measured the lymphedema-specific outpatient out-of-pocket payments over 6 months. The vertical equity of out-of-pocket payments was examined using concentration curves, the Gini coefficient for income, the Kakwani index, and the Reynolds-Smolensky index. We included 231 lymphedema patients aged 7 years or more, living in metropolitan France, and being able to use Internet and email. After voluntary health insurance reimbursement, the mean out-of-pocket payment was equal to 101.4 Euros per month, mainly due to transport (32%) and medical devices (26%). Concentration curves indicated regressivity of out-of-pocket payments. Total out-of-pocket payments represented 10.1% of the income by consumption unit for the poorest quintile and 3.5% for the wealthiest (p<0.05). The Kakwani index for out-of-pocket payments was equal to -0.18. Regarding outpatient health care, French lymphedema patients face significant and regressive out-of-pocket payments, associated with an increased risk of unmet medical needs. Such results shed light on significant socioeconomic inequalities and bring into question the current financing arrangements of outpatient health care in France. Trial registration: ClinicalTrials.gov ID: NCT02988479., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.